Dr. Lucas Brown, DAOM, LAc with Rosedale Acupuncture and Wellness spoke with Studio 512 about offering help to people who are experiencing peripheral neuropathy as a side effect of chemotherapy ...

A French-American research team discovered that the investigational compound Carba1 may prevent chemotherapy-induced peripheral neuropathy (CIPN) in preclinical models. According to a study published ...

Investigators evaluated the long-term impact of taxane chemotherapy on patient-reported neuropathy, balance problems, and falls among older breast cancer survivors.

IDIBELL Researchers of the Neuro-Oncology Unit of Bellvitge University Hospital - Catalan Institute of Oncology, led by Dr. Jordi Bruna, have successfully tested a new molecule capable of preventing ...

Most patients receiving chemotherapy with taxanes or platinum salts develop pain and loss of sensitivity in their hands and feet—a severe side effect that can interfere with proper treatment.

Exercise may improve CIPN symptoms in ovarian cancer patients, though evidence is limited. CIPN is linked to decreased physical function and quality of life, with no consensus on management. Some ...

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech ...

Years after the completion of cancer therapy, 45% of female cancer survivors still experience symptoms of chemotherapy-induced peripheral neuropathy (CIPN), which is a common adverse event, according ...

Chemotherapy has long forced patients to choose between fighting their cancer and living with nerve pain that can linger for years after treatment ends. Now a wave of basic science and early clinical ...

Resilience is often misunderstood as dramatic strength. In reality, it is quieter. It looks like opening your laptop when you are exhausted. It looks like writing through brain fog. It looks like ...